Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$6.63 - $10.69 $5,410 - $8,723
-816 Reduced 26.96%
2,211 $17,000
Q3 2023

Nov 14, 2023

BUY
$4.68 - $9.26 $4,965 - $9,824
1,061 Added 53.97%
3,027 $15,000
Q1 2023

May 15, 2023

SELL
$7.53 - $10.95 $5,594 - $8,135
-743 Reduced 27.43%
1,966 $18,000
Q4 2022

Jun 14, 2023

BUY
$9.44 - $13.09 $7,013 - $9,725
743 Added 37.79%
2,709 $27 Million
Q3 2022

Jun 14, 2023

BUY
$8.14 - $12.25 $6,048 - $9,101
743 Added 37.79%
2,709 $32.3 Million
Q2 2022

Jun 20, 2023

BUY
$6.99 - $10.0 $5,193 - $7,430
743 Added 37.79%
2,709 $22,000
Q1 2022

Jun 20, 2023

BUY
$7.26 - $10.7 $5,394 - $7,950
743 Added 37.79%
2,709 $21,000
Q1 2022

Mar 30, 2023

SELL
$7.26 - $10.7 $59,706 - $87,996
-8,224 Reduced 75.22%
2,709 $21,000
Q1 2022

May 12, 2022

SELL
$7.26 - $10.7 $59,706 - $87,996
-8,224 Reduced 75.22%
2,709 $22,000
Q4 2021

Jun 21, 2023

BUY
$8.8 - $16.0 $78,909 - $143,472
8,967 Added 456.1%
10,933 $102,000
Q4 2021

Mar 30, 2023

SELL
$8.8 - $16.0 $2,745 - $4,992
-312 Reduced 2.77%
10,933 $102,000
Q4 2021

Feb 15, 2022

SELL
$8.8 - $16.0 $2,745 - $4,992
-312 Reduced 2.77%
10,933 $102,000
Q3 2021

Jun 21, 2023

BUY
$15.23 - $21.72 $141,319 - $201,539
9,279 Added 471.97%
11,245 $177,000
Q2 2021

Jun 21, 2023

BUY
$17.8 - $23.5 $165,166 - $218,056
9,279 Added 471.97%
11,245 $243,000
Q2 2021

Mar 30, 2023

BUY
$17.8 - $23.5 $19,473 - $25,709
1,094 Added 10.78%
11,245 $243,000
Q2 2021

Aug 16, 2021

BUY
$17.8 - $23.5 $199,983 - $264,022
11,235 Added 112350.0%
11,245 $243,000
Q1 2021

Jun 26, 2023

BUY
$17.18 - $22.6 $140,618 - $184,981
8,185 Added 416.33%
10,151 $206 Million
Q1 2021

Mar 30, 2023

SELL
$17.18 - $22.6 $13,366 - $17,582
-778 Reduced 7.12%
10,151 $205,000
Q1 2021

May 14, 2021

SELL
$17.18 - $22.6 $187,588 - $246,769
-10,919 Reduced 99.91%
10 $206,000
Q4 2020

Jun 22, 2023

BUY
$11.5 - $17.96 $103,074 - $160,975
8,963 Added 455.9%
10,929 $195,000
Q3 2020

Jun 26, 2023

BUY
$10.62 - $13.12 $95,187 - $117,594
8,963 Added 455.9%
10,929 $127,000
Q2 2020

Jun 26, 2023

BUY
$7.35 - $10.81 $65,878 - $96,890
8,963 Added 455.9%
10,929 $100,000
Q1 2020

Jul 12, 2023

BUY
$8.38 - $17.34 $75,109 - $155,418
8,963 Added 455.9%
10,929 $113,000
Q4 2019

Jul 12, 2023

BUY
$11.18 - $18.6 $100,206 - $166,711
8,963 Added 455.9%
10,929 $195,000
Q3 2019

Jul 12, 2023

BUY
$12.09 - $20.46 $108,362 - $183,382
8,963 Added 455.9%
10,929 $136,000
Q2 2019

Jul 12, 2023

BUY
$18.5 - $25.47 $165,815 - $228,287
8,963 Added 455.9%
10,929 $216,000
Q1 2019

Jul 13, 2023

BUY
$14.62 - $22.13 $131,039 - $198,351
8,963 Added 455.9%
10,929 $230,000
Q1 2019

Mar 30, 2023

BUY
$14.62 - $22.13 $120,176 - $181,908
8,220 Added 303.43%
10,929 $230,000
Q1 2019

May 16, 2019

SELL
$14.62 - $22.13 $25,804 - $39,059
-1,765 Reduced 13.9%
10,929 $230,000
Q1 2019

May 15, 2019

BUY
$14.62 - $22.13 $25,804 - $39,059
1,765 Added 16.15%
12,694 $997,000
Q4 2018

Jul 13, 2023

BUY
$17.09 - $38.25 $153,177 - $342,834
8,963 Added 455.9%
10,929 $223,000
Q4 2018

Feb 14, 2019

BUY
$17.09 - $38.25 $145,880 - $326,502
8,536 Added 356.71%
10,929 $223,000
Q3 2018

Jul 13, 2023

BUY
$34.05 - $55.9 $305,190 - $501,031
8,963 Added 455.9%
10,929 $403 Million
Q3 2018

Nov 14, 2018

SELL
$34.05 - $55.9 $290,650 - $477,162
-8,536 Reduced 78.1%
2,393 $88,000
Q2 2018

Aug 15, 2018

BUY
$36.15 - $52.5 $57,080 - $82,897
1,579 Added 16.89%
10,929 $0
Q4 2017

Feb 15, 2018

SELL
$18.5 - $28.6 $195,230 - $301,815
-10,553 Reduced 53.02%
9,350 $265,000
Q2 2017

Aug 14, 2017

BUY
N/A
19,903
19,903 $333,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $534M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.